Alopurinol - Moligand™, ≥98% , Xanthine dehydrogenase inhibitor, CAS No.315-30-0, Xanthine dehydrogenase inhibitor

CAS: 315-30-0 Cat. No.: A105386 Peso molecular: 136.11 Beilstein Registry Number: 26(3/4)4298 Número EC: 206-250-9
Disponible para pedir
GRADE & PURITY Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. ≥98%
Synonyms
HPP | 4H-pirazolo[3,4-d]pirimidin-4-ona, 1,5-dihidro- | Dabrosin | DTXSID50892275 | Xanturat | 4-Hidroxipirazolil(3,4-d)pirimidina | O11481 | Zyloric | 1,5-Dihidro-4H-pirazolo(3,4-d)pirimidin-4-ona | 1H-pirazolo[3,4-d]pirimidin-4(2H)-ona | 4-Hidroxipirazo
Storage
Room temperature
Shipped In
Normal
 ·  off list, applied to all prices below.
Size
Estado
Price
Qty
5g
A105386-5g
4
9,90US$
10g
A105386-10g
1
10,90US$
25g
A105386-25g
4
13,90US$
100g
A105386-100g
2
30,90US$
500g
A105386-500g
8-12 wks(?) Production requires sourcing of materials. We appreciate your patience and understanding.
132,90US$
Enter a quantity for the sizes you want to add.
🧪

Why this grade

Moligand™, ≥98% Moligand™ for sensitive chromatographic and analytical workflows requiring minimal baseline interference.

🌡

Storage & shipping

Room temperature Ships Normal Check lot-specific COA for exact specifications.

📋

Quality documents

SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.

📚

Literature proof

Cited in 48 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.

Descripción general

El alopurinol es un inhibidor antiurolítico de la xantina oxidasa que disminuye la producción de ácido úrico.
Un inhibidor antiurolítico de la xantina oxidasa

Specifications

Sinónimos
HPP | 4H-pirazolo[3, 4-d]pirimidin-4-ona, 1, 5-dihidro- | Dabrosin | DTXSID50892275 | Xanturat | 4-Hidroxipirazolil(3, 4-d)pirimidina | O11481 | Zyloric | 1, 5-Dihidro-4H-pirazolo(3, 4-d)pirimidin-4-ona | 1H-pirazolo[3, 4-d]pirimidin-4(2H)-ona | 4-Hidroxipirazo
Especificaciones y pureza
Moligand™, ≥98%
Mecanismos bioquímicos y fisiológicos
Inhibidor de la xantina oxidasa (IC 50 = 0, 2 - 50 μM). Análogo de purina antihiperuricémico. Inhibe la producción de ácido úrico in vivo. Neuroprotector. Activo in vivo .
Condiciones de almacenamiento de almacenamiento
Room temperature
Enviado en
Normal
Grado
Moligand™
Tipo de acción
INHIBITOR
Mecanismo de acción
Xanthine dehydrogenase inhibitor
Nota
Siempre que sea posible, prepare y utilice las soluciones el mismo día. Sin embargo, si necesita preparar soluciones madre con antelación, le recomendamos que almacene la solución como alícuotas en viales herméticamente cerrados a -20°C. Por lo general, podrán utilizarse durante un mes. Antes de su uso, y antes de abrir el vial, le recomendamos que deje que el producto se equilibre a temperatura ambiente durante al menos 1 hora. Toxicidad, consulte la SDS para más información. ¿Necesita más consejos sobre solubilidad, uso y manipulación? Visite nuestra página de preguntas frecuentes (FAQ) para obtener más información.
Pureza
≥98%
Nombres e identificadores
Pubchem Sid504773260
Pubchem Sid Urlhttps://pubchem.ncbi.nlm.nih.gov/substance/504773260
Sonrisas canónicasC1=NNC2=C1C(=O)NC=N2
IUPAC Name1,5-dihydropyrazolo[3,4-d]pyrimidin-4-one
InChIKeyOFCNXPDARWKPPY-UHFFFAOYSA-N
INCHI1S/C5H4N4O/c10-5-3-1-8-9-4(3)6-2-7-5/h1-2H,(H2,6,7,8,9,10)
Isómeros SMILES C1=NNC2=C1C(=O)NC=N2
WGK Alemania 2
RTECS UR0785000
Número ONU 2811
Grupo de embalaje I
Peso molecular 136.11
Beilstein 26(3/4)4298
Reaxy-Rn 133199
Reaxys-RN_link_address https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=133199&ln=

Documentation

📋 Safety Data Sheet (SDS)

Comprehensive hazard, handling, storage, and regulatory compliance document.

Download SDS →

✅ Certificate of Analysis (COA)

Lot-specific quality data. Enter your lot number to retrieve the exact COA.

Look up COA →

📊 Datasheet

Quick-reference summary of product specifications and applications.

View datasheet →

🔬 Specification Sheet

Full quality attributes and acceptance criteria for this grade.

View spec sheet →

Advanced Data

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassOrganoheterocyclic compounds
ClasePyrazolopyrimidines
SubclassPyrazolo[3,4-d]pyrimidines
Intermediate Tree Nodes Not available
Direct ParentPyrazolo[3,4-d]pyrimidines
Alternative Parents Pyrimidones  Vinylogous amides  Pyrazoles  Heteroaromatic compounds  Azacyclic compounds  Organopnictogen compounds  Organooxygen compounds  Organonitrogen compounds  Organic oxides  Hydrocarbon derivatives  
Molecular FrameworkAromatic heteropolycyclic compounds
Substituents Pyrazolo[3,4-d]pyrimidine - Pyrimidone - Pyrimidine - Azole - Pyrazole - Vinylogous amide - Heteroaromatic compound - Azacycle - Organonitrogen compound - Organic oxygen compound - Organic nitrogen compound - Organooxygen compound - Hydrocarbon derivative - Organic oxide - Organopnictogen compound - Aromatic heteropolycyclic compound
DescripciónThis compound belongs to the class of organic compounds known as pyrazolo[3,4-d]pyrimidines. These are aromatic heterocyclic compounds containing a pyrazolo[3,4-d]pyrimidine ring system, which consists of a pyrazole ring fused to but and not sharing a nitrogen atom with a pyrimidine ring.
External Descriptors a small molecule
Estructura 3D
Modelo de Estructura Química Interactiva





Objetivos asociados (humanos)
XDH Tclin Xanthine dehydrogenase/oxidase (11 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
PDE5A Tclin Phosphodiesterase 5A (5113 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EGFR Tclin Epidermal growth factor receptor erbB1 (33727 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
F2 Tclin Thrombin (11687 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CA2 Tclin Carbonic anhydrase II (17698 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ESR1 Tclin Estrogen receptor alpha (17718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HMGCR Tclin HMG-CoA reductase (2475 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NR3C1 Tclin Glucocorticoid receptor (14987 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
INSR Tclin Insulin receptor (5558 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PGR Tclin Progesterone receptor (8562 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB2 Tclin Beta-2 adrenergic receptor (11824 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM2 Tclin Muscarinic acetylcholine receptor M2 (10671 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB1 Tclin Beta-1 adrenergic receptor (6630 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR1A Tclin Serotonin 1a (5-HT1a) receptor (14969 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA2A Tclin Alpha-2a adrenergic receptor (9450 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AR Tclin Androgen Receptor (11781 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM1 Tclin Muscarinic acetylcholine receptor M1 (12690 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACE Tclin Angiotensin-converting enzyme (1423 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD2 Tclin Dopamine D2 receptor (23596 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TYR Tclin Tyrosinase (717 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GABRA1 Tclin GABA receptor alpha-1 subunit (399 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TSHR Tclin Thyroid stimulating hormone receptor (29986 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAOA Tclin Monoamine oxidase A (11911 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CNR1 Tclin Cannabinoid CB1 receptor (20913 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD1 Tclin Dopamine D1 receptor (9720 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD4 Tchem Dopamine D4 receptor (7907 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACHE Tclin Acetylcholinesterase (18204 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGS1 Tclin Cyclooxygenase-1 (9233 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A2 Tclin Norepinephrine transporter (10102 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HRH2 Tclin Histamine H2 receptor (5428 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA1D Tclin Alpha-1d adrenergic receptor (4171 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAOB Tclin Monoamine oxidase B (8835 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR1B Tclin Serotonin 1b (5-HT1b) receptor (2801 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2A Tclin Serotonin 2a (5-HT2a) receptor (14758 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2C Tclin Serotonin 2c (5-HT2c) receptor (11471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AVPR2 Tclin Vasopressin V2 receptor (2912 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA1 Tclin Adenosine A1 receptor (17603 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AGTR1 Tclin Type-1 angiotensin II receptor (5176 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CALCR Tclin Calcitonin receptor (2215 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A4 Tclin Serotonin transporter (12625 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CRHR1 Tclin Corticotropin releasing factor receptor 1 (2996 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA1A Tclin Alpha-1a adrenergic receptor (8359 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGS2 Tclin Cyclooxygenase-2 (13999 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HRH1 Tclin Histamine H1 receptor (7573 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA1B Tclin Alpha-1b adrenergic receptor (2912 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRM1 Tclin Mu opioid receptor (19785 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD3 Tclin Dopamine D3 receptor (14368 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AVPR1A Tclin Vasopressin V1a receptor (5412 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRD1 Tclin Delta opioid receptor (15096 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRK1 Tclin Kappa opioid receptor (16155 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR3A Tclin Serotonin 3a (5-HT3a) receptor (3366 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Objetivos asociados (no humanos)
Agtr2 Angiotensin II type 2 (AT-2) receptor (803 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mc4r Melanocortin receptor 4 (1205 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Ltc4s Leukotriene C4 synthase (1 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Sigmar1 Sigma opioid receptor (160 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Npy1r Neuropeptide Y receptor type 1 (8 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cckar Cholecystokinin A receptor (90 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Ntsr1 Neurotensin receptor 1 (48 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pde4d Phosphodiesterase 4D (4 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Bdkrb1 Bradykinin B1 receptor (77 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Nos2 Nitric oxide synthase, inducible (3573 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mapk1 MAP kinase ERK2 (650 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hdac6 Histone deacetylase 6 (222 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mmp9 Matrix metalloproteinase 9 (38 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pnp Purine nucleoside phosphorylase (4 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hcar2 Hydroxycarboxylic acid receptor 2 (55 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pseudomonas aeruginosa (123386 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Klebsiella pneumoniae (43867 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus aureus (210822 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Acinetobacter baumannii (41033 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Escherichia coli (133304 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pneumocystis carinii (749 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Leishmania infantum (5912 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Trypanosoma brucei (78846 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Trypanosoma brucei brucei (13300 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Entamoeba histolytica (2676 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cryptosporidium parvum (1150 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cryptococcus neoformans (21258 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Candida albicans (78123 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Leishmania amazonensis (3813 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Leishmania donovani (89745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Leishmania major (2877 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Leishmania mexicana (936 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Trypanosoma cruzi (99888 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Trichomonas vaginalis (2376 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Toxoplasma gondii (4585 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Trypanosoma brucei rhodesiense (7991 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
J774.A1 (2436 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PC-12 (7051 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
rep Replicase polyprotein 1ab (378 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Bacillus anthracis (2936 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasma (328 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Xdh Xanthine dehydrogenase/oxidase (52 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Nfe2l2 Nuclear factor erythroid 2-related factor 2 (214 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Glra2 Glycine receptor (1745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
stxA Shiga toxin subunit A (82 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SARS-CoV-2 (38078 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mecanismos de acción
Certificados (CoA, COO, BSE/TSE y tabla de análisis)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

37 results found

Lot NumberCertificate TypeFechaArticulo
E2622226Certificate of AnalysisApr 24, 2026 A105386
E2622186Certificate of AnalysisApr 24, 2026 A105386
E2622185Certificate of AnalysisApr 24, 2026 A105386
E2622184Certificate of AnalysisApr 24, 2026 A105386
I2510191Certificate of AnalysisAug 30, 2025 A105386
I2510189Certificate of AnalysisAug 30, 2025 A105386
I2510188Certificate of AnalysisAug 30, 2025 A105386
I2510186Certificate of AnalysisAug 30, 2025 A105386
G2530054Certificate of AnalysisApr 17, 2025 A105386
E2508109Certificate of AnalysisApr 17, 2025 A105386
E2508108Certificate of AnalysisApr 17, 2025 A105386
E2508107Certificate of AnalysisApr 17, 2025 A105386
E2508106Certificate of AnalysisApr 17, 2025 A105386
L2410267Certificate of AnalysisDec 02, 2024 A105386
L2410261Certificate of AnalysisDec 02, 2024 A105386
C2521219Certificate of AnalysisDec 02, 2024 A105386
D2420008Certificate of AnalysisMar 26, 2024 A105386
D2403684Certificate of AnalysisMar 11, 2024 A105386
D2403683Certificate of AnalysisMar 11, 2024 A105386
C2521208Certificate of AnalysisMar 11, 2024 A105386
E2310743Certificate of AnalysisFeb 26, 2022 A105386
C2215351Certificate of AnalysisFeb 26, 2022 A105386
K2420145Certificate of AnalysisFeb 26, 2022 A105386
K2301039Certificate of AnalysisFeb 26, 2022 A105386
K2301038Certificate of AnalysisFeb 26, 2022 A105386
J2323105Certificate of AnalysisFeb 26, 2022 A105386
C2215368Certificate of AnalysisFeb 26, 2022 A105386
C2215377Certificate of AnalysisFeb 26, 2022 A105386
C2215381Certificate of AnalysisFeb 26, 2022 A105386
H2329112Certificate of AnalysisFeb 26, 2022 A105386
G2319050Certificate of AnalysisFeb 26, 2022 A105386
G2307492Certificate of AnalysisFeb 26, 2022 A105386
D2418065Certificate of AnalysisFeb 26, 2022 A105386
E2310740Certificate of AnalysisFeb 26, 2022 A105386
E2326331Certificate of AnalysisFeb 26, 2022 A105386
J2129366Certificate of AnalysisNov 02, 2021 A105386
A2221059Certificate of AnalysisNov 02, 2021 A105386

Show more ⌵

Propiedades químicas y físicas
SolubilidadInsoluble in water; Degree of Solubility in water: 0.48 g/l 25 °C; Insoluble in Chloroform,Ether,Ethanol
Punto de fusión (°C)384°C
Peso molecular136.110 g/mol
XLogP3-0.700
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count3
Rotatable Bond Count0
Exact Mass136.039 Da
Monoisotopic Mass136.039 Da
Topological Polar Surface Area70.100 Ų
Heavy Atom Count10
Formal Charge0
Complexity190.000
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds0
Covalently-Bonded Unit Count1
Preguntas frecuentes y artículos
Citations of This Product
Referencias
1. Jiana Du, Na Wang, Dehong Yu, Pei He, Yu Gao, Yanbei Tu, Yanfang Li.  (2023)  Data mining-guided alleviation of hyperuricemia by Paeonia veitchii Lynch through inhibition of xanthine oxidase and regulation of renal urate transporters.  PHYTOMEDICINE,      [PMID:38176275] [10.1016/j.phymed.2023.155305]
2. Jie Xiong, Ya-ying Wang, Muhammad Yousaf, Dong-mei Liu.  (2023)  Improvement of Physicochemical Properties and Flavor of Pickled Radish through the Use of a Direct-Vat Set Starter Consisting of Lactiplantibacillus Plantarum and Leuconostoc Mesenteroides.  INTERNATIONAL JOURNAL OF FOOD SCIENCE AND TECHNOLOGY,      [PMID:] [10.1111/ijfs.16731]
3. Yawen Wang, Longjian Zhou, Minqi Chen, Yayue Liu, Yu Yang, Tiantian Lu, Fangfang Ban, Xueqiong Hu, Zhongji Qian, Pengzhi Hong, Yi Zhang.  (2023)  Mining Xanthine Oxidase Inhibitors from an Edible Seaweed Pterocladiella capillacea by Using In Vitro Bioassays, Affinity Ultrafiltration LC-MS/MS, Metabolomics Tools, and In Silico Prediction.  Marine Drugs,  21  (10): (502).  [PMID:37888437] [10.3390/md21100502]
4. Xueqin Wang, Zhenzhen Cui, Yuan Luo, Yu Huang, Xinbin Yang.  (2023)  In vitro xanthine oxidase inhibitory and in vivo anti-hyperuricemic properties of sodium kaempferol-3′-sulfonate.  FOOD AND CHEMICAL TOXICOLOGY,      [PMID:37230458] [10.1016/j.fct.2023.113854]
5. Jiling Song, Minghui Chen, Fanlei Meng, Jiahui Chen, Zhanwei Wang, Yong Zhang, Jing Cui, Jing Wang, Dongfang Shi.  (2023)  Studies on the interaction mechanism between xanthine oxidase and osmundacetone: Molecular docking, multi-spectroscopy and dynamical simulation.  SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY,      [PMID:37209475] [10.1016/j.saa.2023.122861]
6. Jianmin Chen, Zemin He, Sijin Yu, Xiaozhen Cai, Danhong Zhu, Yanhua Lin.  (2023)  Xanthine oxidase inhibitory kinetics and mechanism of ellagic acid: In vitro, in silico and in vivo studies.  IET Nanobiotechnology,  17  (4): (368-375).  [PMID:37153957] [10.1049/nbt2.12135]
7. Yi-Fang Gao, Meng-Qi Liu, Zhong-Han Li, Han-Lin Zhang, Jia-Qi Hao, Bo-Hao Liu, Xiao-Yan Li, Yu-Qi Yin, Xiao-Hui Wang, Qian Zhou, Di Xu, Bao-Ming Shi, Ying-Hua Zhang.  (2023)  Purification and identification of xanthine oxidase inhibitory peptides from enzymatic hydrolysate of α-lactalbumin and bovine colostrum casein.  FOOD RESEARCH INTERNATIONAL,      [PMID:37254330] [10.1016/j.foodres.2023.112882]
8. Jinhua Li, Namrta Choudhry, Gang Lv, Naganna Nimishetti, Mallu Chenna Reddy, Hong Liu, Thaddeus D. Allen, Jing Zhang, Dun Yang.  (2023)  In-vitro metabolism of LXY18, an orally available, potent blocker of AURKB relocation in mitosis.  JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS,      [PMID:37120975] [10.1016/j.jpba.2023.115415]
9. Jiling Song, Zhanwei Wang, Yu Chi, Yong Zhang, Chenyi Fang, Yuting Shu, Jing Cui, Helong Bai, Jing Wang.  (2023)  Anti-gout activity and the interaction mechanisms between Sanghuangporus vaninii active components and xanthine oxidase.  BIOORGANIC CHEMISTRY,      [PMID:36801789] [10.1016/j.bioorg.2023.106394]
10. Yingling Sui, Deping Xu, Xiulan Sun.  (2023)  Identification of anti-hyperuricemic components from Coix seed.  Food Bioscience,      [PMID:] [10.1016/j.fbio.2023.102461]
11. Rui Wang, Han Wang, Guohua Jiang, Yanfang Sun, Tianqi Liu, Lei Nie, Amin Shavandi, Khaydar E. Yunusov, Uladzislau E. Aharodnikau, Sergey O. Solomevich.  (2022)  Transdermal delivery of allopurinol to acute hyperuricemic mice via polymer microneedles for the regulation of serum uric acid levels.  Biomaterials Science,  11  (5): (1704-1713).  [PMID:36628631] [10.1039/D2BM01836E]
12. Yin Wan, Dengxiao Wang, Yuefeng Shen, Yanru Chen, Jin Qian, Guiming Fu.  (2022)  Effect of Lactobacillus acidophilus fermentation on the composition of chlorogenic acids and anti-hyperuricemia activity of Artemisia selengensis Turcz.  Food & Function,  13  (22): (11780-11793).  [PMID:36300542] [10.1039/D2FO01854C]
13. Gao Tianshu, Xu Jin, Xiao Yuxiao, Li Jiaqi, Hu Weifeng, Su Xiaoyu, Shen Xudong, Yu Wan, Chen Zhen, Huang Baosheng, Li Honglei, Wang Xing.  (2022)  Therapeutic effects and mechanisms of N-(9,10-anthraquinone-2-ylcarbonyl) xanthine oxidase inhibitors on hyperuricemia.  Frontiers in Pharmacology,      [PMID:36120294] [10.3389/fphar.2022.950699]
14. Yawen Lian, Xiang Yuan, Yandan Wang, Lin Wei.  (2022)  Highly sensitive visual colorimetric sensor for xanthine oxidase detection by using MnO2-nanosheet-modified gold nanoparticles.  SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY,      [PMID:35397450] [10.1016/j.saa.2022.121219]
15. Rui Sun, Juan Kan, Huahao Cai, Jinhai Hong, Changhai Jin, Man Zhang.  (2022)  In vitro and in vivo ameliorative effects of polyphenols from purple potato leaves on renal injury and associated inflammation induced by hyperuricemia.  JOURNAL OF FOOD BIOCHEMISTRY,  46  (2): (e14049).  [PMID:34981522] [10.1111/jfbc.14049]
16. Liyan Yuan, Zhijie Bao, Tiecheng Ma, Songyi Lin.  (2021)  Hypouricemia effects of corn silk flavonoids in a mouse model of potassium oxonated-induced hyperuricemia.  JOURNAL OF FOOD BIOCHEMISTRY,  45  (8): (e13856).  [PMID:34250618] [10.1111/jfbc.13856]
17. Yin Wan, Jin Qian, Yizhen Li, Yuefeng Shen, Yanru Chen, Guiming Fu, Mingyong Xie.  (2021)  Inhibitory mechanism of xanthine oxidase activity by caffeoylquinic acids in vitro.  INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES,      [PMID:34146563] [10.1016/j.ijbiomac.2021.06.075]
18. Caixin Ni, Xin Li, Linlin Wang, Xiu Li, Jianxin Zhao, Hao Zhang, Gang Wang, Wei Chen.  (2021)  Lactic acid bacteria strains relieve hyperuricaemia by suppressing xanthine oxidase activity via a short-chain fatty acid-dependent mechanism.  Food & Function,  12  (15): (7054-7067).  [PMID:34152353] [10.1039/D1FO00198A]
19. Shi Feng, Chen Lin, Wang Yaping, Liu Jing, Adu-Frimpong Michael, Ji Hao, Toreniyazov Elmurat, Wang Qilong, Yu Jiangnan, Xu Ximing.  (2021)  Enhancement of oral bioavailability and anti-hyperuricemic activity of aloe emodin via novel Soluplus®—glycyrrhizic acid mixed micelle system.  Drug Delivery and Translational Research,  12  (3): (603-614).  [PMID:33860450] [10.1007/s13346-021-00969-8]
20. Xie Jiahong, Cui Haoxin, Xu Yang, Xie Lianghua, Chen Wei.  (2021)  Delphinidin-3-O-sambubioside: a novel xanthine oxidase inhibitor identified from natural anthocyanins.  Food Quality and Safety,      [PMID:] [10.1093/fqsafe/fyaa038]
21. Qian Zhou, Jia-Yi Yin, Wei-Yue Liang, Dong-Mei Chen, Qing Yuan, Bao-long Feng, Ying-Hua Zhang, Yu-Tang Wang.  (2021)  Various machine learning approaches coupled with molecule simulation in the screening of natural compounds with xanthine oxidase inhibitory activity.  Food & Function,  12  (4): (1580-1589).  [PMID:33470259] [10.1039/D0FO03059G]
22. Yanzuo Le, Xie Zhou, Jiawen Zheng, Fangmiao Yu, Yunping Tang, Zuisu Yang, Guofang Ding, Yan Chen.  (2020)  Anti-Hyperuricemic Effects of Astaxanthin by Regulating Xanthine Oxidase, Adenosine Deaminase and Urate Transporters in Rats.  Marine Drugs,  18  (12): (610).  [PMID:33271765] [10.3390/md18120610]
23. Yi Tao, Lin Chen, Enci Jiang.  (2020)  Layer-by-layer assembly strategy for fabrication of polydopamine-polyethyleneimine hybrid modified fibers and their application to solid-phase microextraction of bioactive molecules from medicinal plant samples followed by surface plasmon resonance biosensor validation.  ANALYTICA CHIMICA ACTA,      [PMID:33461711] [10.1016/j.aca.2020.11.016]
24. Xingchu Gong, Jingyuan Shao, Shangxin Guo, Jingjing Pan, Xiaohui Fan.  (2020)  Determination of inhibitory activity of Salvia miltiorrhiza extracts on xanthine oxidase with a paper-based analytical device.  Journal of Pharmaceutical Analysis,      [PMID:34765273] [10.1016/j.jpha.2020.09.004]
25. Xiao-Wei Zhang, Mei Zhou, Lin An, Ping Zhang, Ping Li, Jun Chen.  (2020)  Lipophilic Extract and Tanshinone IIA Derived from Salvia miltiorrhiza Attenuate Uric Acid Nephropathy through Suppressing Oxidative Stress-Activated MAPK Pathways.  AMERICAN JOURNAL OF CHINESE MEDICINE,  48  (06): (1455-1473).  [PMID:32933312] [10.1142/S0192415X20500718]
26. Wen Weng, Qilong Wang, Chunmei Wei, Na Man, Kangyi Zhang, Qiuyu Wei, Michael Adu-Frimpong, Elmurat Toreniyazov, Hao Ji, Jiangnan Yu, Ximing Xu.  (2019)  Preparation, characterization, pharmacokinetics and anti-hyperuricemia activity studies of myricitrin-loaded proliposomes.  INTERNATIONAL JOURNAL OF PHARMACEUTICS,      [PMID:31705971] [10.1016/j.ijpharm.2019.118735]
27. Zhang Kangyi, Wang Qilong, Yang Qiuxuan, Wei Qiuyu, Man Na, Adu-Frimpong Michael, Toreniyazov Elmurat, Ji Hao, Yu Jiangnan, Xu Ximing.  (2019)  Enhancement of Oral Bioavailability and Anti-hyperuricemic Activity of Isoliquiritigenin via Self-Microemulsifying Drug Delivery System.  AAPS PHARMSCITECH,  20  (5): (1-11).  [PMID:31187334] [10.1208/s12249-019-1421-0]
28. Yin Wan, Fen Wang, Bin Zou, Yuefeng Shen, Yizhen Li, Axi Zhang, Guiming Fu.  (2019)  Molecular mechanism underlying the ability of caffeic acid to decrease uric acid levels in hyperuricemia rats.  Journal of Functional Foods,      [PMID:] [10.1016/j.jff.2019.03.038]
29. Tianqiao Yong, Shaodan Chen, Yizhen Xie, Diling Chen, Jiyan Su, Ou Shuai, Huiping Hu, Dan Zuo, Danling Liang.  (2018)  Hypouricemic Effects of Armillaria mellea on Hyperuricemic Mice Regulated through OAT1 and CNT2.  AMERICAN JOURNAL OF CHINESE MEDICINE,  46  (03): (585-599).  [PMID:29595077] [10.1142/S0192415X18500301]
30. Yin Wan, Yu-Xi Liang, Bin Zou, Gui-Ming Fu, Ming-Yong Xie.  (2018)  The possible mechanism of hydroxytyrosol on reducing uric acid levels.  Journal of Functional Foods,      [PMID:] [10.1016/j.jff.2018.01.009]
31. Jing Wang, Dongfang Shi, Meizhu Zheng, Bing Ma, Jing Cui, Chunming Liu, Chengyu Liu.  (2017)  Screening, separation, and evaluation of xanthine oxidase inhibitors from Paeonia lactiflora using chromatography combined with a multi-mode microplate reader.  JOURNAL OF SEPARATION SCIENCE,  40  (21): (4160-4167).  [PMID:28857450] [10.1002/jssc.201700690]
32. Zeynep Tohtahon, Lu Zhang, Jianxin Han, Xing Xie, Zongcai Tu, Tao Yuan.  (2017)  Extraction optimization, structural characterization and bioactivity evaluation of triterpenoids from hawthorn (Crataegus cuneata) fruits.  JOURNAL OF FOOD BIOCHEMISTRY,  41  (4): (e12377).  [PMID:] [10.1111/jfbc.12377]
33. Hongjin Tang, Lin Yang, Wei Li, Jiahuang Li, Jun Chen.  (2016)  Exploring the interaction between Salvia miltiorrhiza and xanthine oxidase: insights from computational analysis and experimental studies combined with enzyme channel blocking.  RSC Advances,  (114): (113527-113537).  [PMID:] [10.1039/C6RA24396G]
34. Yin Wan, Bin Zou, Hailong Zeng, Lunning Zhang, Ming Chen, Guiming Fu.  (2016)  Inhibitory effect of verbascoside on xanthine oxidase activity.  INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES,      [PMID:27616694] [10.1016/j.ijbiomac.2016.09.022]
35. Fu Yu, Mo Hua-Yan, Gao Wen, Hong Jia-Ying, Lu Jun, Li Ping, Chen Jun.  (2014)  Affinity selection-based two-dimensional chromatography coupled with high-performance liquid chromatography-mass spectrometry for discovering xanthine oxidase inhibitors from Radix Salviae Miltiorrhizae.  ANALYTICAL AND BIOANALYTICAL CHEMISTRY,  406  (20): (4987-4995).  [PMID:24866714] [10.1007/s00216-014-7902-9]
36. Xiaoyue Zhang, Linfeng Liu, Zhaosen Fan, Nilufar Mamadalieva, Chao Liu, Xu Guo, Shutao Sun, Hui Sun, Ningyang Li, Muxuan Wang.  (2025)  Bioactive Evaluation of Naringenin in Ameliorating Hyperuricemia-Induced Liver Injury by Inhibiting Xanthine Oxidase.  eFood,  (1): (e70032).  [PMID:] [10.1002/efd2.70032]
37. Zexuan Xu, Miaoyu Gan, Weiliang Guan, Fang Tian, Yuxi Wang, Jinjie Zhang, Luyun Cai.  (2025)  In Slico Screening and In Vitro Identification of Hyperuricemia-Inhibiting Peptides from Trachurus japonicus.  Foods,  14  (3): (524).  [PMID:39942117] [10.3390/foods14030524]
38. Rui Wang, Han Wang, Rui Yao, Yan Li, Sedrati Manar, Lei Nie, Khaydar E. Yunusov, Jianwei Pan, Guohua Jiang.  (2025)  Iontophoresis-driven transdermal drug delivery system based on porous microneedles for hyperuricemia treatment.  INTERNATIONAL JOURNAL OF PHARMACEUTICS,      [PMID:39880144] [10.1016/j.ijpharm.2025.125290]
39. Xiaoran Kong, Li Zhao, He Huang, Qiaozhen Kang, Jike Lu, Jia-Qing Zhu.  (2025)  Isorhamnetin Ameliorates Hyperuricemia by Regulating Uric Acid Metabolism and Alleviates Renal Inflammation Through the PI3K/AKT/NF-κB Signaling Pathway.  Food & Function,      [PMID:40111208] [10.1039/D4FO04867A]
40. Maiquan Li, Cui Li, Tiantian Tao, Wenlan Li, Manjun Kang, Peitao Fu, Xia Liu, Wei Quan, Mingzhi Zhu, Zhonghua Liu.  (2025)  Study on the synergistical effects of characteristic compounds in Osmanthus black tea against xanthine oxidase based on multispectral analysis combined with in silico studies.  INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES,      [PMID:40154674] [10.1016/j.ijbiomac.2025.142479]
41. Jie Xiong, Jia-Juan Wu, Dong-mei Liu, Muhammad Yousaf, Liu-Jun Liu, Suping Zeng, Qinqin Li, Jun Tang, Yaping Wu.  (2024)  The alleviating effects and mechanisms of Lactiplantibacillus plantarum MC14 on hyperuricemia in mice.  Food Bioscience,      [PMID:] [10.1016/j.fbio.2024.105256]
42. Can Yang, Haiqi Xu, Puchen Zhao, Qin Yin, Na Wang, Lizi Li, Yan Liu, Yanfang Li.  (2025)  Molecular insights from multi-spectroscopy and computer simulations investigation on the xanthine oxidase inhibition by 2′,4′-dimethoxy-4-hydroxychalcone.  BIOORGANIC CHEMISTRY,      [PMID:40695095] [10.1016/j.bioorg.2025.108745]
43. Yuanfan Wu, Xia Sun, Yuhan Jia, Tianshu Gao, Jin Xu, Youqiao Qian, Naiqi Pei, Lilin Wang, Qiaohong Zheng, Honglei Li, Zhen Chen, Yijiao Liu, Yang Ma, Hui Chen, Yuanyuan Ye, Jiaxin Zhao, Yi Zhou, Xiaoqing Chen, Baosheng Huang, Yefeng Liu, Yin Zhu, Ning Xue, Juan Zhang, Guangfeng Ji, Xing Wang.  (2025)  Therapeutic effect and mechanism of gigantol on hyperuricemia.  Frontiers in Endocrinology,      [PMID:40801026] [10.3389/fendo.2025.1474808]
44. Cong Zhang, Yangkun Xiong, Mingyang Gong, Haixia Zhao, Shan Li, Xin Chen, Xiaochuan Ye, Zhenpeng Qiu.  (2025)  Pachymic Acid Ameliorates Fructose-Driven Hyperuricemic Nephropathy in Mice by Suppressing Ferroptosis via Activating Nrf2/GPX-4 Pathway.  JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY,      [PMID:40864644] [10.1021/acs.jafc.5c02398]
45. Jiana Du, Yan Liu, Lizi Li, Qin Yin, Dehong Yu, Pei He, Na Wang, Ruiying Yuan, Zhujun Yin, Yanbei Tu, Yanfang Li.  (2025)  Natural Polyphenol Pentagalloyl Glucose as a Potent Xanthine Oxidase Inhibitor for Hyperuricemia Treatment.  JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY,      [PMID:40847943] [10.1021/acs.jafc.5c04078]
46. Xiqian Tan, Anqi Sun, Shuaibo Gao, Zixiao Shen, Lijun You, Fangchao Cui, Xuepeng Li, Jianrong Li.  (2025)  Weissella cibaria X1 fermentation enhances the UA-lowering ability of Carthamus tinctorius L. via metabolic regulation.  Food Bioscience,      [PMID:] [10.1016/j.fbio.2025.107643]
47. Guosen Ou, Jialin Wu, Shiqi Wang, Wensong Bi, Rui Peng, Pei Liu, Yawen Jiang, Yaokang Chen, Huachong Xu, Li Deng, Huan Zhao, Xiaoyin Chen, Lu Xu.  (2026)  Plantago asiatica L. extract alleviates hyperuricemia-associated renal injury by modulating gut microbiota to inhibit NLRP3 inflammasome activation.  PHYTOMEDICINE,      [PMID:41539089] [10.1016/j.phymed.2026.157771]
48. Jiawei Huang, Qianqian Wang, Xiaowen Guo, Yuanyuan Niu, Junhong Huang, Boyi Zhang, Zixuan Guo, Zilong Wang, Shuying Feng.  (2026)  Unraveling the mechanism of mulberry leaf in alleviating hyperuricemia: key role of kaempferol by modulating AKT pathway and gut-kidney axis.  Frontiers in Microbiology,      [PMID:41657898] [10.3389/fmicb.2026.1752775]
Calculadoras de soluciones
Reseñas

Reseñas de cliente

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.